MedTrace Logo

The Influence Cirrhosis of the Liver on the Coronary Re-stenosis (LTX- Stent Study)

NCT02809248 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2018-07-17

No results posted yet for this study

Summary

The aim of the study is to choose an optimal stent and to get further knowledge about the mechanisms of the engraftment of a stent.

The occurrence of a hyperplasia of neointima can be minimized by application of a coated stent and a concurrent safety four weekly dual thrombocytes therapy

Conditions

  • Re-stenosis
  • Cirrhosis of the Liver

Interventions

DEVICE

ZES

stent implantation (zotarolimus eluting stent)

DEVICE

BMS

stent implantation (bare metal stent)

Sponsors & Collaborators

  • RWTH Aachen University

    lead OTHER

Principal Investigators

  • Michael Becker, MD · Uniklinik RWTH Aachen, Med. Klinik I

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-07-31
Primary Completion
2017-12-31
Completion
2017-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02809248 on ClinicalTrials.gov